GRCE Competitors & Alternatives
Compare Grace Therapeutics, Inc. with similar stocks in the same industry
Biotechnology
GRCE
Main Stock$2.20
Tradestie Score
52
Market Cap
$42.45M
Analyst Upside
+170.6%
Top Competitors
227 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AVTX
Avalo Therapeutics, Inc. Common Stock
|
$16.35
|
$170.45M | - | 52 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$11.00
|
$133.50M | - | 50 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$21.22
|
$110.20M | - | 55 | Compare |
|
IRD
Opus Genetics, Inc. Common Stock
|
$4.26
|
$107.83M | - | 53 | Compare |
|
CNTB
Connect Biopharma Holdings Limited Ordinary Shares
|
$2.35
|
$83.60M | - | 47 | Compare |
|
UNCY
Unicycive Therapeutics, Inc. Common Stock
|
$8.08
|
$78.68M | - | 55 | Compare |
|
STRO
Sutro Biopharma, Inc.
|
$25.57
|
$76.55M | - | 50 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$7.04
|
$71.69M | - | 54 | Compare |
|
OSTX
OS Therapies Incorporated
|
$1.73
|
$63.29M | - | 54 | Compare |
|
NEUP
Neuphoria Therapeutics Inc. Common Stock
|
$5.48
|
$26.04M | - | 53 | Compare |
More GRCE Analysis
Data updated: May 26, 2026 | Industry: Biotechnology (SIC 2834)
227 stocks in this industry